|
BIBLIOGRAFÍA
-
Adams MR, BrandonEP, Chartoff EH, ldzerda RL, Dorsa DM and McKnight GS (1997) Loss of haloperidol-induced gene expression and catalepsy in protein kinase A-deficient mice. Proe Natl Acad USA 94: 12157-12161.
-
Andersen HL and Kilpatrick IC (1996) Prevention by (±)-8-hydroxy-2-(dinpropylamino) tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol. Br J Pharmacol 118: 421-427.
-
Asper H, Baggiolini M, Burki FIR, Lauener H, Ruch W and Stille G /1973) Tolerance phenomena with neuroleptics: Catalepsy, aporphine stereotypy and striatal doparrime metabolism in the rat afther single and repeated administration of loxapine and haloperidol. Eur J Pharmacol 22: 287-294.
-
Baldessarini RJ (1990) Drugs and the treatment of psychiatric disorders, in The Pharmacological Basis of Therapeutics (Gilman AG, Rall TW, Nies AS and Taylor P eds) pp 383-404, Pergamon Press, New York.
-
Béhé P, Stern P, Wyllie DJ, Nassar M, Schoepfer R and Colquhoun D (1995) Determination of NMDA NR 1 subunit copy number in recombinant NMDA receptors. Proe R Soc Lon B Biol Sci 262: 205-213.
-
Bergson C, Mrzijak L, Smiley J17, Pappy M, Levenson R and GoldinanRakic PS (1995) Regional, cellular, -and subcellular variations in the distribution of D, and D, dopamine receptors in primate brain. J Neurosci 15: 7821-7836.
-
Bittiger H., Froesti W, Mickel S. T. and Olpe H.R.: GABA, receptor antagonists: From synthesis to therapeutic applications. Trends Pharmacol. Sci. 14: 391-394, 1993,
-
Borowski TB and Kokkinidis L (1996) Contribution of ventral tegmental area dopamine neurons to expression of conditional fear: Effects of electrical stimulation, excitotoxin lesions, and quinpirole infusion on potentiated startle in rats. Behav Neurosci 110: 13491364.
-
Casey DE (1993) Serotonergic and dopaminergic aspects of neuroleptic-induced extrapyramidal syndromes in nonhuman primates. Psychopharmacology 112: S55-S59.
-
Cauli B, Audinat E, Lambolez B, Angulo M.C., Ropert N, Tsrizuki K, Hestrin S. and Rossier J.: Molecular and physiological diversity of cortical nonpyramidal cells. J. Neurosci. 17: 3894-3906, 1997.
-
Corbett r, Camacho F, Woods AT., Kerman L.L. Fishkin RJ., Brooks K. and Dunn R. W.: Antipsychotic agents antagonize non-competitive N-methil-D-aspartate antagonist-induced behaviors. Psychophamacology 120: 67-74, 1995.
-
Daly D.A. and Moghaddam B.: Actions of haloperidol on the extracellular levels of excitatory mino acids in the prefrontal cortex and striatum of conscious rats. Neurosci Lett. 152: 61-64, 1993.
-
Foote SL. and Aston-Jones GS 81995) Pharmacology and physiology of central noradrenergic systems, in Psychopharmacology: The Fourth Generation of Progress (Bloom FE and Kupfer DJ eds) pp 347-354, Raven Press, Ltd., New York.
-
Gerfen CR and Wilson CJ (1996) The basal ganglia, in Handbook of Chemical Neuroanatomy (Bjorklund A and Hokfelt T eds) pp 371-468, Elsevier Science, New York.
-
Ghosh A and Greenberg ME (1995) Calcium signaling in neurons: Molecular mechanisms and cellular consequences. Science (Wash DC) 268: 239-247.
-
Knable MB and Weinberger DR (1997) Dopamine, the prefonal cortex and chizophrenia, J Psychopharmacology 11: 123-13 1.
-
Levant B (1997) The D, dopamine receptor: Neurobiology and potential clinical relevance. Pharmacol Rev 49: 231-252.
-
Millan MJ, Gobert A, Newman-Tancredi A, Audinot V, Lejeune F, Rivet JM, Cussac D, Nicolas JPm Muller O and lavielle G (1998a) S 16924(+) -2(2(2,3- dihydrobenzo (1,4) dioxin-5yloxy)-ethyl-pyrrolidin-3yl} -1 -4(fluoro-phenyl) ethanone), a novel, potential antipsychotic with marked scrotonin (5HT), agonist properties. I, Receptonal and ricurochernical profile in comparison with clozapine and haloperidol. J Pharmacol Exp Ther. 286: 1341-1355.
-
Missale C, Nash SR, Robinson SW, Jaber M and Caron MG (1998) Dopamine receptors: From structure to function. Physiol Rev 78: 189-225.
-
Sanberg PR (1980) Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors. Nature 284: 472-473.
|
|
